ROCKVILLE, Md., Oct. 28 /PRNewswire-FirstCall/ — Vanda
Pharmaceuticals Inc. (Vanda) (Nasdaq:
VNDA), a biopharmaceutical company focused on the development
and commercialization of products for central nervous system
disorders, today announced it will release results for the third
quarter of 2010, on Wednesday, November 3, 2010, before the market
opens. A full text copy of the release will be disseminated at that
Mihael H. Polymeropoulos, M.D., President and Chief Executive
Officer, will host a conference call to discuss the results at
10:00 AM ET on Wednesday, November 3, 2010. To participate in
the conference call, dial the appropriate number below shortly
before the 10:00 AM start time and ask for the Vanda
Pharmaceuticals conference call hosted by Dr. Polymeropoulos.The
teleconference dial-in numbers are as follows:Domestic callers
1-866-730-5768International callers 1-857-350-1592Participant
Passcode 11659354The conference call will be broadcast
simultaneously and archived on the Company’s website, www.vandapharma.com.
Investors should go to the website at least 15 minutes early to
register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, November 3,
2010, beginning at 1:00 PM ET and will be accessible until
Wednesday, November 10, 2010, at 5:00 PM ET. The replay call-in
number is 1-888-286-8010 for domestic callers and 1-617-801-6888
for international callers. The access number is 14475834.
ABOUT VANDA PHARMACEUTICALS INC.:Vanda Pharmaceuticals Inc.
is a biopharmaceutical company focused on the development and
commercialization of products for central nervous system disorders.
For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.
CONTACT: Cristina Murphy, Communi